FN2 Earnings Intelligence
Gilead Sciences, Inc. ratios (quarterly)
Gilead Sciences, Inc. (GILD) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $5,037 | $7,926 | $5,144 | $7,330 | $7,628 |
| + Debt | $23,249 | $24,952 | $24,946 | $24,941 | $22,174 |
| Enterprise Value | - | - | - | - | - |
| Revenue | $7,545 | $6,667 | $7,082 | $7,769 | $6,960 |
| % Growth | - | - | - | - | - |
| Gross Profit | $5,971 | $5,127 | $5,581 | $6,200 | $5,515 |
| % Margin | 79.1% | 76.9% | 78.8% | 79.8% | 79.2% |
| EBITDA | - | $2,334 | $2,567 | $3,417 | $2,679 |
| % Margin | - | 35.0% | 36.2% | 44.0% | 38.5% |
| Net Income | $1,253 | $1,315 | $1,960 | $3,052 | $2,021 |
| % Margin | 16.6% | 19.7% | 27.7% | 39.3% | 29.0% |
| Diluted EPS | $1.00 | $1.04 | $1.56 | $2.43 | $1.61 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | - | $1,757 | - | - | $2,544 |
| CapEx | - | $104 | - | - | $117 |
| Free Cash Flow | - | $1,653 | - | - | $2,427 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue | $7,545 | $6,667 | $7,082 | $7,769 | $6,960 |
| Gross Profit | $5,971 | $5,127 | $5,581 | $6,200 | $5,515 |
| EBITDA | - | $2,334 | $2,567 | $3,417 | $2,679 |
| Net Income | $1,253 | $1,315 | $1,960 | $3,052 | $2,021 |
| Diluted EPS | $1.00 | $1.04 | $1.56 | $2.43 | $1.61 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5,037 | $7,926 | $5,144 | $7,330 | $7,628 |
| Short-term Debt | $1,812 | $2,806 | $2,806 | $2,806 | $1,313 |
| Long-term Debt | $21,437 | $22,146 | $22,140 | $22,135 | $20,861 |
| Total Debt | $23,249 | $24,952 | $24,946 | $24,941 | $22,174 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $1,757 | - | - | $2,544 |
| Capital Expenditure | - | $104 | - | - | $117 |
| Free Cash Flow | - | $1,653 | - | - | $2,427 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 79.1% | 76.9% | 78.8% | 79.8% | 79.2% |
| EBITDA Margin | - | 35.0% | 36.2% | 44.0% | 38.5% |
| Net Margin | 16.6% | 19.7% | 27.7% | 39.3% | 29.0% |
| FCF Margin | - | 24.8% | - | - | 34.9% |
| Diluted EPS Growth | - | - | - | - | - |